Pharmacopeia Announces Date of First Quarter 2001 Earnings Release And Conference Call

Apr 25, 2001, 01:00 ET from Pharmacopeia, Inc.

    PRINCETON, N.J., April 25 /PRNewswire/ --
 Pharmacopeia, Inc. (Nasdaq:   PCOP) today announced it plans to release its
 financial results for the first quarter of 2001 after the Nasdaq market closes
 on Wednesday, May 2, 2001.  The Company will conduct a conference call and an
 audio webcast at 5:00 p.m. EDT on the same day.
     Dr. Joseph Mollica, Chairman, President, and CEO, and Bruce C. Myers,
 Executive Vice President and Chief Financial Officer will host the call.
 Forward-looking and other material information may be discussed on this
 conference call.
 
     Conference call numbers are as follows:
 
     Domestic callers:                   (800) 360-9865
     International callers:              (973) 694-6836
     Webcast information can be
     accessed through:                   www.pharmacopeia.com
                                         or
                                         www.streetfusion.com
 
     A replay of the conference call, which can be accessed by dialing
 toll-free (800) 428-6051, and outside the U.S. (973) 709-2089, will be
 available for 2 weeks.  The access code is 180085.
     Pharmacopeia (www.pharmacopeia.com) is a leader in enabling science and
 technology that accelerates and improves the drug discovery and chemical
 development processes.  Pharmacopeia's Software segment develops and
 commercializes molecular modeling and simulation software for the life
 sciences and materials research, cheminformatics and decision support systems,
 and bioinformatics tools for gene sequence analysis.  The business also
 provides consulting services to its customers in drug discovery and chemical
 development.  Pharmacopeia's Drug Discovery segment integrates proprietary
 small molecule combinatorial and medicinal chemistry, high-throughput
 screening, in-vitro pharmacology, computational methods and informatics to
 discover and optimize lead compounds and to accelerate customers' drug
 discovery efforts.  Pharmacopeia employs approximately 750 people, generated
 2000 revenues of approximately $119 million, and is headquartered in
 Princeton, NJ.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X12321323
 
 

SOURCE Pharmacopeia, Inc.
    PRINCETON, N.J., April 25 /PRNewswire/ --
 Pharmacopeia, Inc. (Nasdaq:   PCOP) today announced it plans to release its
 financial results for the first quarter of 2001 after the Nasdaq market closes
 on Wednesday, May 2, 2001.  The Company will conduct a conference call and an
 audio webcast at 5:00 p.m. EDT on the same day.
     Dr. Joseph Mollica, Chairman, President, and CEO, and Bruce C. Myers,
 Executive Vice President and Chief Financial Officer will host the call.
 Forward-looking and other material information may be discussed on this
 conference call.
 
     Conference call numbers are as follows:
 
     Domestic callers:                   (800) 360-9865
     International callers:              (973) 694-6836
     Webcast information can be
     accessed through:                   www.pharmacopeia.com
                                         or
                                         www.streetfusion.com
 
     A replay of the conference call, which can be accessed by dialing
 toll-free (800) 428-6051, and outside the U.S. (973) 709-2089, will be
 available for 2 weeks.  The access code is 180085.
     Pharmacopeia (www.pharmacopeia.com) is a leader in enabling science and
 technology that accelerates and improves the drug discovery and chemical
 development processes.  Pharmacopeia's Software segment develops and
 commercializes molecular modeling and simulation software for the life
 sciences and materials research, cheminformatics and decision support systems,
 and bioinformatics tools for gene sequence analysis.  The business also
 provides consulting services to its customers in drug discovery and chemical
 development.  Pharmacopeia's Drug Discovery segment integrates proprietary
 small molecule combinatorial and medicinal chemistry, high-throughput
 screening, in-vitro pharmacology, computational methods and informatics to
 discover and optimize lead compounds and to accelerate customers' drug
 discovery efforts.  Pharmacopeia employs approximately 750 people, generated
 2000 revenues of approximately $119 million, and is headquartered in
 Princeton, NJ.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X12321323
 
 SOURCE  Pharmacopeia, Inc.